MedTrace Logo

Evaluation of Dexamethasone Added to the Usual Infiltration With Bupivacaine in Inguinal Hernia Repair Mesh

NCT03007927 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2018-02-22

No results posted yet for this study

Summary

To evaluate the impact on the postoperative pain of the dexamethasone addition to the usual treatment with bupivacaine in the local infiltration of the surgical area in Inguinal Hernia Repair Mesh

Conditions

  • Pain, Postoperative

Interventions

DRUG

Bupivacaine-Dexamethasone

Bupivacaine 1,5 mg/kg-Dexamethasone 2ml 8 mg

DRUG

Bupivacaine- physiological solution

Bupivacaine 1,5 mg/kg- physiological solution

Sponsors & Collaborators

  • Sebastián Roche, MD

    collaborator UNKNOWN

  • Santiago Bertone, MD

    collaborator UNKNOWN

  • Claudio Brandi, MD

    collaborator UNKNOWN

  • SEBASTIAN ROCHE

    lead OTHER

Principal Investigators

  • Sebastian SR Roche, doctor · Hospital Italiano de Buenos Aires

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2016-12-31
Completion
2017-06-29

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03007927 on ClinicalTrials.gov